AMDA Stock Overview
A venture capital firm specializing in seed, start up, early venture and middle market investments.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Almeda Ventures Limited Partnership Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪1.80 |
52 Week High | ₪2.50 |
52 Week Low | ₪1.63 |
Beta | -0.77 |
11 Month Change | -0.44% |
3 Month Change | 4.35% |
1 Year Change | -15.09% |
33 Year Change | -70.32% |
5 Year Change | n/a |
Change since IPO | -76.94% |
Recent News & Updates
Recent updates
Shareholder Returns
AMDA | IL Capital Markets | IL Market | |
---|---|---|---|
7D | 0% | -0.05% | -2.1% |
1Y | -15.1% | 1.0% | -3.1% |
Return vs Industry: AMDA underperformed the IL Capital Markets industry which returned 1.8% over the past year.
Return vs Market: AMDA underperformed the IL Market which returned -1.9% over the past year.
Price Volatility
AMDA volatility | |
---|---|
AMDA Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 3.9% |
Market Average Movement | 4.3% |
10% most volatile stocks in IL Market | 7.4% |
10% least volatile stocks in IL Market | 3.0% |
Stable Share Price: AMDA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AMDA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | n/a | Irit Yaniv | www.almedaventures.com |
Almeda Ventures Limited Partnership is a venture capital firm specializing in seed, start up, early venture and middle market investments. The firm seeks to invest in health technology with focus on public R&D partnership, medical devices, digital health and bio-convergence; life sciences research and development company. It prefers to invest in Israel, USA and Europe.
Almeda Ventures Limited Partnership Fundamentals Summary
AMDA fundamental statistics | |
---|---|
Market cap | ₪22.27m |
Earnings (TTM) | -₪5.91m |
Revenue (TTM) | n/a |
-20.4x
P/S Ratio-3.8x
P/E RatioIs AMDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AMDA income statement (TTM) | |
---|---|
Revenue | -US$292.00k |
Cost of Revenue | US$36.00k |
Gross Profit | -US$328.00k |
Other Expenses | US$1.25m |
Earnings | -US$1.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.13 |
Gross Margin | 112.33% |
Net Profit Margin | 541.78% |
Debt/Equity Ratio | 0% |
How did AMDA perform over the long term?
See historical performance and comparison